Taselisib (GDC 0032)
Taselisib (GDC 0032, RG7604) is a potent, next-generation β isoform-sparing PI3K inhibitor targeting PI3Kα/δ/γ with Ki of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3Kβ.
Trivial name | RG7604 |
Catalog Number | S7103 |
Molecular Formula | C24H28N8O2 |
CAS# | 1282512-48-4 |
Inchi | InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33) |
Inchi Key | BEUQXVWXFDOSAQ-UHFFFAOYSA-N |
SMILES | CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C |
Size | 10mM/1mL |
Supplier Page | http://www.selleckchem.com/products/gdc-0032.html |
Additional Information | https://file.selleck.cn/downloads/struct/GDC-0032-RG-7604-chemical-structure-s7103.gif |